Autologous activated macrophages (MAK™) coatedex vivowith humanized anti-CD20 monoclonal antibodies can eradicate minimal residual disease in chronic lymphocytic leukaemia in clinical response

2008 ◽  
Vol 142 (6) ◽  
pp. 996-998 ◽  
Author(s):  
Laurent Sutton ◽  
Driss Chaoui ◽  
Bruno Cazin ◽  
Nabih Azar ◽  
Mohamed Chokri ◽  
...  
Keyword(s):  
Monoclonal Antibodies ◽  
Chronic Lymphocytic Leukaemia ◽  
Clinical Response ◽  
Minimal Residual Disease ◽  
Lymphocytic Leukaemia ◽  
Residual Disease ◽  
Activated Macrophages ◽  
Anti Cd20 ◽  
Minimal Residual

scholarly journals Absence of Minimal Residual Disease Detectable by Facs, Southern Blot or PCR in Patients with Chronic Lymphocytic Leukaemia Treated with Fludarabine

1994 ◽  
Vol 33 (6) ◽  
pp. 627-630 ◽  
Author(s):  
Deborah S. Richardson ◽  
Stephen A. Johnson ◽  
John A. Hopkins ◽  
Denise Howe ◽  
Malcolm J. Phillips
Keyword(s):  
Chronic Lymphocytic Leukaemia ◽  
Southern Blot ◽  
Minimal Residual Disease ◽  
Lymphocytic Leukaemia ◽  
Residual Disease ◽  
Minimal Residual
Sign in / Sign up

Export Citation Format

Share Document